| abstract |
The present invention relates to a compound of formula (I), or a pharmaceutically acceptable enantiomer, salt, or solvate thereof. The present invention further relates to the use of compounds of formula I as TDO2 inhibitors. The invention also relates to the use of compounds of formula I for the treatment and / or prevention of HIV, depression and obesity. The invention also relates to a process for the preparation of the compound of formula (I). [Chemical 1] |